HOME Research Insight Market Leader - Molecular Biology Enzymes and Kits & Reagents Market

Market Leader - Molecular Biology Enzymes and Kits & Reagents Market

The global molecular biology enzymes and kits & reagents market is projected to reach USD 13.60 Billion by 2022 from USD 6.52 Billion in 2017, at a CAGR of 15.8%. The molecular biology enzymes and kits & reagents market is well established owing to the dominance by prominent market players. In 2016, Thermo Fisher (US), Merck (Germany), and Illumina (US) held a share of 70% to 75% of the overall market.

Thermo Fisher Scientific dominated the molecular biology enzymes and kits & reagents market in 2016. The company provides a wide range of products in this market, including transfection reagents, cloning kits, cloning reagents, PCR enzymes & master mixes, PCR reagents, DNA extraction reagents & kits, and genome editing kits. These products are made available through Thermo Fisher Scientific’s strong sales force and a global network of resellers and distributors. The company has approximately 12,000 sales and service personnel, including highly trained technical specialists. Acquisitions, agreements, and collaborations have also enabled the company to expand its product portfolio and enter emerging markets.

In March 2016, Thermo Fisher Scientific acquired Affymetrix to enhance its antibody product portfolio. In September 2015, the company acquired Alfa Aesar to increase its manufacturing capabilities for research chemicals. Acquisitions; collaboration and agreements; expansion; increasing R&D expenditure; a broad product portfolio; and an extensive distribution and sales network across the globe have enabled Thermo Fishers Scientific to dominate the molecular biology enzymes and kits & reagents market.

Merck designs and manufactures products for academic research markets, applied testing customers, the pharmaceutical & biotechnology industry, and molecular diagnostics laboratories. With the acquisition of Sigma-Aldrich Corporation (US), Merck secured the second-leading position in the global market (with a share of 23.1% in 2016). Sigma-Aldrich was one of the leading developers, manufacturers, and distributors of molecular biology enzymes and kits & reagents. By acquiring Sigma-Aldrich, Merck became a leader in the global life science industry, which valued at more than USD 113 billion (€ 100 billion). The acquisition considerably expanded Merck’s geographic footprint, especially in North America. Merck is present in North America, Europe, APAC, Latin America, and the Middle East & Africa, with ~50,000 employees working at 72 production locations across 66 countries. The firm has 130 global distribution centers.

Some of the other players competing in this market are Illumina (US), QIAGEN (Netherlands), New England Biolabs (US), Promega (US), Agilent (US), Roche (Switzerland), Takara Bio (Japan), Bio Basic (Canada), Jena Bioscience (Germany), and Molecular Biology Resources (US).

Related Reports:

Molecular Biology Enzymes and Kits & Reagents Market by Product (Kits & Reagents, Enzymes), Application (PCR, Sequencing, Cloning, Epigenetics), End User (Academic & Research Institutes, Hospitals & Diagnostic Centers), and Region - Global Forecast to 2022

Mr. Rohan
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support

US : 1-888-600-6441

Search reports